XML 50 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of Significant Expense Categories Provided to CODM

The following table is representative of the significant expense categories regularly provided to the CODM when managing the Company’s single reportable segment:

 

 

 

Year Ended
December 31,

 

 

2024

 

 

2023

 

Revenues(1)

 

$

2,392

 

 

$

709

 

Less:

 

 

 

 

 

 

Cost of revenues

 

 

508

 

 

 

488

 

R&D costs(2)

 

 

2,799

 

 

 

5,704

 

G&A costs(3)

 

 

5,646

 

 

 

6,869

 

Personnel costs(4)

 

 

9,002

 

 

 

7,731

 

Other segment items(5)

 

 

410

 

 

 

1,330

 

Net loss

 

$

(15,973

)

 

$

(21,413

)

 

(1) Includes Contract Manufacturing and Clinical Trial revenue

(2) Includes Clinical Development, Research & Discovery, CMC

(3) Includes Executive, Finance, Legal, Business Operations

(4) Includes compensation, benefits and equity-based compensation

(5) Includes depreciation and amortization, (interest income) and other specific charges